131 related articles for article (PubMed ID: 1992993)
1. Transient and distant infections alter later intraperitoneal abscess formation.
Sawyer RG; Adams RB; Spengler MD; Pruett TL
Arch Surg; 1991 Feb; 126(2):164-8. PubMed ID: 1992993
[TBL] [Abstract][Full Text] [Related]
2. Preexposure of the peritoneum to live bacteria increases later mixed intraabdominal abscess formation and delays mortality.
Sawyer RG; Adams RB; Spengler MD; Pruett TL
J Infect Dis; 1991 Mar; 163(3):664-7. PubMed ID: 1995742
[TBL] [Abstract][Full Text] [Related]
3. Nosocomial bacteremia-induced increases in abscess formation correlate with in vitro upregulation of macrophage procoagulant activity.
Sawyer RG; Pruett TL
Crit Care Med; 1995 Sep; 23(9):1554-9. PubMed ID: 7664558
[TBL] [Abstract][Full Text] [Related]
4. Immunization-induced changes in later intra-abdominal abscess formation are mediated by cellular and humoral mechanisms.
Sawyer RG; Adams RB; Spengler MD; Pruett TL
Curr Surg; 1990; 47(5):331-4. PubMed ID: 2257748
[No Abstract] [Full Text] [Related]
5. CD4+ T cells mediate preexposure-induced increases in murine intraabdominal abscess formation.
Sawyer RG; Adams RB; May AK; Rosenlof LK; Pruett TL
Clin Immunol Immunopathol; 1995 Oct; 77(1):82-8. PubMed ID: 7554488
[TBL] [Abstract][Full Text] [Related]
6. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.
Onderdonk AB; Shapiro ME; Finberg RW; Zaleznik DF; Kasper DL
Rev Infect Dis; 1984; 6 Suppl 1():S91-5. PubMed ID: 6372042
[TBL] [Abstract][Full Text] [Related]
7. In-vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses.
Wells CL; Arland LA; Simmons RL; Rotstein OD
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():199-206. PubMed ID: 3897172
[TBL] [Abstract][Full Text] [Related]
8. The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.
Sawyer RG; Adams RB; Rosenlof LK; May AK; Pruett TL
Am Surg; 1995 Aug; 61(8):726-31. PubMed ID: 7618816
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of peritoneal cells from rats after intra-abdominal infection with Bacteroides fragilis and Escherichia coli.
Verweij WR; Namavar F; Schouten WF; Kostense PJ; Pellenkoft M; De Graaff J; MacClaren DM
J Med Microbiol; 1993 Jan; 38(1):13-8. PubMed ID: 8380297
[TBL] [Abstract][Full Text] [Related]
10. Effects of anti-Bacteroides-antibodies on Escherichia coli and different Bacteroides species in vitro and vivo.
Rodloff AC; Hilliger F; Friedman H; Hahn H
Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):483-91. PubMed ID: 3541458
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of intraabdominal abscess formation: abscess-potentiating agents and inhibition of complement-dependent opsonization of abscess-inducing bacteria.
Finlay-Jones JJ; Kenny PA; Nulsen MF; Spencer LK; Hill NL; McDonald PJ
J Infect Dis; 1991 Dec; 164(6):1173-9. PubMed ID: 1659600
[TBL] [Abstract][Full Text] [Related]
12. Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses.
Dunn DL; Barke RA; Ewald DC; Simmons RL
Infect Immun; 1985 May; 48(2):287-91. PubMed ID: 3886544
[TBL] [Abstract][Full Text] [Related]
13. T cell regulation of Bacteroides fragilis-induced intraabdominal abscesses.
Crabb JH; Finberg R; Onderdonk AB; Kasper DL
Rev Infect Dis; 1990; 12 Suppl 2():S178-84. PubMed ID: 2406870
[TBL] [Abstract][Full Text] [Related]
14. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
Brook I; Ledney GD
J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
[TBL] [Abstract][Full Text] [Related]
15. Induction of an atypical interferon by bacteroides fragilis and Escherichia coli in experimental infections and in leukocyte cultures.
Blanchard DK; Rodloff AC; Steward WE; Hahn H; Friedman H
Infection; 1986; 14(6):289-93. PubMed ID: 2434431
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
Rotstein OD; Kao J; Houston K
J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
[TBL] [Abstract][Full Text] [Related]
17. Synergy in polymicrobial infections in a mouse model of type 2 diabetes.
Mastropaolo MD; Evans NP; Byrnes MK; Stevens AM; Robertson JL; Melville SB
Infect Immun; 2005 Sep; 73(9):6055-63. PubMed ID: 16113326
[TBL] [Abstract][Full Text] [Related]
18. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA
Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
[TBL] [Abstract][Full Text] [Related]
19. The kinetics of peritoneal clearance of Escherichia coli and Bacteroides fragilis and participating defense mechanisms.
Skau T; Nyström PO; Ohman L; Stendahl O
Arch Surg; 1986 Sep; 121(9):1033-9. PubMed ID: 3527110
[TBL] [Abstract][Full Text] [Related]
20. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.
Onderdonk AB; Markham RB; Zaleznik DF; Cisneros RL; Kasper DL
J Clin Invest; 1982 Jan; 69(1):9-16. PubMed ID: 6976357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
